Raffaele Cerullo

Dr. Raffaele Cerullo

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 May 2021 in European Archives of Oto-Rhino-Laryngology
Verified
Journal Article
Closed access
PDF file
DLD. Lucidi
D. Lucidi
CFCristoforo Fabbris
Cristoforo Fabbris
RCRaffaele Cerullo
Raffaele Cerullo
SGS. Di Gioia
S. Di Gioia
FCF. Calvaruso
F. Calvaruso
LPL. Presutti
L. Presutti

Verified
Journal Article
Open access
PDF file
SGSandra Gazzini
Sandra Gazzini
RCRaffaele Cerullo
Raffaele Cerullo
Davide SolopertoDavide Soloperto
Davide Soloperto
Recurrent respiratory papillomatosis (RRP) is a benign disease of the upper aerodigestive tract caused by human papillomavirus (HPV) types 6 and 11. The clinical course is unpredictable and some patients, especially younger children, experience a high rate of recurrence with a significant impact on their quality of life. The molecular mechanisms of HPV infection in keratinocytes have been extensively studied throughout the years, with particular regard to its role in causing malignant tumors, like cervical cancer and head and neck carcinomas. A minor but not negligible amount of the literature has investigated the molecular landscape of RRP patients, and some papers have studied the role of angiogenesis (the growth of blood vessels from pre-existing vasculature) in this disease. A central role in this process is played by vascular endothelial growth factor (VEGF), which activates different signaling cascades on multiple levels. The increased knowledge has led to the introduction of the VEGF inhibitor bevacizumab in recent years as an adjuvant treatment in some patients, with good results. This review summarizes the current evidence about the role of VEGF in the pathophysiology of RRP, the molecular pathways activated by binding with its receptors, and the current and future roles of anti-angiogenic treatment.

9 May 2023 in European Archives of Oto-Rhino-Laryngology
Verified
Journal Article
Closed access
PDF file
Davide SolopertoDavide Soloperto
Davide Soloperto
ELElisa Laura
Elisa Laura
LGLuca Gazzini
Luca Gazzini
RCRaffaele Cerullo
Raffaele Cerullo
GFGiuseppe Ferrulli
Giuseppe Ferrulli
DMDaniele Marchioni
Daniele Marchioni

Verified
Journal Article
Open access
PDF file
Davide SolopertoDavide Soloperto
Davide Soloperto
SGSandra Gazzini
Sandra Gazzini
RCRaffaele Cerullo
Raffaele Cerullo
Primary tumors of the airways in the pediatric population are very rare entities. For this reason, little is known about the pathogenesis of these neoplasms. Understanding the biology has different practical implications: for example, it could help in the differential diagnosis, have a prognostic significance, or may lead to the development of a targeted therapy. The aim of this article is to present the current knowledge about pediatric airways tumors, focusing on the molecular mechanisms that cause the onset and progression of these neoplasms. After a brief introduction of epidemiology and clinical presentation, the tumorigenesis of the most frequent pediatric airways tumors will be described: Juvenile-onset recurrent respiratory papillomatosis (JORRP), Subglottic Hemangiona (SH), Rhabdomyosarcoma (RMS), and Mucoepidermoid carcinoma (MEC).

4 February 2022 in European Annals of Otorhinolaryngology, Head and Neck Diseases
Verified
Journal Article
Closed access
RCRaffaele Cerullo
Raffaele Cerullo
PCP. Criscenti
P. Criscenti
GMGabriele Molteni
Gabriele Molteni

1 September 2021 in European Annals of Otorhinolaryngology, Head and Neck Diseases
Verified
Journal Article
Closed access
ELE. Laura
E. Laura
RCRaffaele Cerullo
Raffaele Cerullo
LGL. Gazzini
L. Gazzini